In Vitro Activities of Six New Fluoroquinolones against Brucella melitensis

AUTOR(ES)

Trujillano-Martín, Ignacio

FONTE

American Society for Microbiology

RESUMO

We have tested the in vitro activities of eight fluoroquinolones against 160 Brucella melitensis strains. The most active was sitafloxacin (MIC at which 90% of the isolates are inhibited [MIC90], 0.12 μg/ml). In decreasing order, the activities (MIC90s) of the rest of the tested fluoroquinolones were as follows: levofloxacin, 0.5 μg/ml; ciprofloxacin, trovafloxacin, and moxifloxacin, 1 μg/ml; and ofloxacin, grepafloxacin, and gatifloxacin, 2 μg/ml.

Documentos Relacionados

• Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.
• Comparison of E Test to Microdilution for Determining In Vitro Activities of Antibiotics against Brucella melitensis
• Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones.
• Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.
• In vitro activities of new macrolides and rifapentine against Brucella spp.